To keep a stable therapeutic level of cyclosporine during the early posttransplant period is important in graft survival.
Ahn
M S
MS
Department of Surgery, Seoul National University Hospital, Korea.
Ha
J
J
Yun
I J
IJ
Kim
S
S
Lee
J S
JS
Kim
S
S
Han
J S
JS
Ahn
C
C
Choi
Y
Y
Cheong
H I
HI
Kim
S T
ST
Kim
S J
SJ
D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D002675:Child, Preschool; D016572:Cyclosporine / Q000097:blood / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D005260:Female; D005500:Follow-Up Studies; D006085:Graft Survival; D006801:Humans; D007166:Immunosuppressive Agents / Q000097:blood / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology / Q000502:physiology*; D008297:Male; D008875:Middle Aged; D011239:Prednisolone / Q000627:therapeutic use; D012189:Retrospective Studies; D013997:Time Factors
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D011239:Prednisolone